PLx Pharma Inc.

Symbol: PLXP

NASDAQ

0.12

USD

Market price today

  • -0.0400

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 3.50M

    MRK Cap

  • 0.00%

    DIV Yield

PLx Pharma Inc. (PLXP) Stock Price & Analysis

Shares Outstanding

29.14M

Gross Profit Margin

0.41%

Operating Profit Margin

-4.97%

Net Profit Margin

-6.27%

Return on Assets

-0.67%

Return on Equity

-1.66%

Return on Capital Employed

-0.63%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO:Ms. Natasha Giordano
Full-time employees:16
City:Sparta
Address:9 Fishers Lane
IPO:2014-03-13
CIK:0001497504

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

General Outlook

In simple terms, PLx Pharma Inc. has 29.138 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.415% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -4.970%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -6.269%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.671% return, is a testament to PLx Pharma Inc.'s adeptness in optimizing resource deployment. PLx Pharma Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.656%. Furthermore, the proficiency of PLx Pharma Inc. in capital utilization is underscored by a remarkable -0.630% return on capital employed.

Stock Prices

PLx Pharma Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.0095, while its low point bottomed out at $0.009. This variance in figures offers investors a lucid insight into the roller-coaster ride that is PLx Pharma Inc.'s stock market.

Liquidity Ratios

Analyzing PLXP liquidity ratios reveals its financial health of the firm. The current ratio of 618.54% gauges short-term asset coverage for liabilities. The quick ratio (589.49%) assesses immediate liquidity, while the cash ratio (584.16%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio618.54%
Quick Ratio589.49%
Cash Ratio584.16%

Profitability Ratios

PLXP profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -561.95% underscores its earnings before tax deductions. The effective tax rate stands at -11.57%, revealing its tax efficiency. The net income per EBT, 111.57%, and the EBT per EBIT, 113.08%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -496.95%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-561.95%
Effective Tax Rate-11.57%
Net Income per EBT111.57%
EBT per EBIT113.08%
EBIT per Revenue-496.95%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 6.19, it details the span from stock purchase to revenue. The 6 days it takes to settle debts showcases its creditor relations. Meanwhile, a 6 cash conversion cycle and 1294.64% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding589
Days of Inventory Outstanding187
Operating Cycle214.91
Days of Payables Outstanding805
Cash Conversion Cycle-590
Receivables Turnover12.95
Payables Turnover0.45
Inventory Turnover1.95
Fixed Asset Turnover7.54
Asset Turnover0.11

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -1.36, and free cash flow per share, -1.36, depict cash generation on a per-share basis. The cash per share value, 2.93, showcases liquidity position. A payout ratio of -0.16 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -3.91, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-1.36
Free Cash Flow per Share-1.36
Cash per Share2.93
Payout Ratio-0.16
Operating Cash Flow Sales Ratio-3.91
Free Cash Flow to Operating Cash Flow Ratio1.00
Dividend Paid and Capex Coverage Ratio-4.00
Dividend Payout Ratio0.04

Debt and Leverage Ratios

An interest coverage of -40790.00 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage-40790.00
Company Equity Multiplier1.48

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.35, provides a glimpse into top-line earnings distributed across each share. Net income per share, -2.18, reflects the portion of profit attributed to each share. The book value per share, 2.19, represents the net asset value distributed per share, while the tangible book value per share, 2.10, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.35
Net Income Per Share-2.18
Book Value Per Share2.19
Tangible Book Value Per Share2.10
Shareholders Equity Per Share2.19

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 120,048,160.57, captures the company's total value, considering both debt and equity. Income quality, 0.70, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value120,048,160.57
Income Quality0.70
Research and Development to Revenue50.95%
Intangibles to Total Assets2.69%
Stock-Based Compensation to Revenue35.14%
Graham Number10.34
Return on Tangible Assets-69.00%
Graham Net Net1.95
Working Capital61,597,000
Tangible Asset Value49,619,000
Net Current Asset Value48,514,000
Average Receivables317,000
Average Payables5,731,284
Average Inventory1,300,690
Days Sales Outstanding28
Days Payables Outstanding805
Days of Inventory On Hand187
ROIC-88.06%
ROE-1.00%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.04, and the price to book ratio, 0.04, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.31, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.08, and price to operating cash flows, -0.06, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.04
Price to Book Ratio0.04
Price to Sales Ratio0.31
Price Cash Flow Ratio-0.06
Enterprise Value Multiple-2.04
Price Fair Value0.04
Price to Operating Cash Flow Ratio-0.06
Price to Free Cash Flows Ratio-0.08
Price to Tangible Book Ratio3.67
Enterprise Value to Sales14.63
Enterprise Value Over EBITDA-3.41
EV to Operating Cash Flow-3.74
Earnings Yield-27.16%
Free Cash Flow Yield-16.95%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of PLx Pharma Inc. (PLXP) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.040 in 2024.

What is the ticker symbol of PLx Pharma Inc. stock?

The ticker symbol of PLx Pharma Inc. stock is PLXP.

What is company IPO date?

IPO date of PLx Pharma Inc. is 2014-03-13.

What is company current share price?

Current share price is 0.120 USD.

What is stock market cap today?

The market cap of stock today is 3496524.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 16.